2018
DOI: 10.1016/j.stem.2018.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma

Abstract: Tumor growth and relapse are driven by tumor propagating cells (TPCs). However, mechanisms regulating TPC fate choices, maintenance, and self-renewal are not fully understood. Here, we show that Van Gogh-like 2 (Vangl2), a core regulator of the non-canonical Wnt/planar cell polarity (Wnt/PCP) pathway, affects TPC self-renewal in rhabdomyosarcoma (RMS)-a pediatric cancer of muscle. VANGL2 is expressed in a majority of human RMS and within early mononuclear progenitor cells. VANGL2 depletion inhibited cell proli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
48
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2
2

Relationship

2
8

Authors

Journals

citations
Cited by 62 publications
(51 citation statements)
references
References 57 publications
(115 reference statements)
1
48
1
Order By: Relevance
“…Unexpectedly, kRAS G12D -induced tumors harboring wild-type tp53 had similar frequency of tumor-propagating stem cells when compared with those of tp53 del/del ERMS (n ≥ 3 tumors analyzed per genotype, p=0.647 EDLA analysis, Table 1 ). We concluded that Tp53 loss-of-function does not alter the overall frequency of tumor-sustaining, cancer stem cells in ERMS, which contrasts with previous studies that defined major roles for NOTCH1, MYF5/MYOD, and WNT signaling in regulating self-renewal and the overall number of tumor sustaining cell types in rhabdomyosarcoma ( Chen et al, 2014 ; Hayes et al, 2018 ; Ignatius et al, 2017 ; Tenente et al, 2017 ).…”
Section: Resultscontrasting
confidence: 99%
“…Unexpectedly, kRAS G12D -induced tumors harboring wild-type tp53 had similar frequency of tumor-propagating stem cells when compared with those of tp53 del/del ERMS (n ≥ 3 tumors analyzed per genotype, p=0.647 EDLA analysis, Table 1 ). We concluded that Tp53 loss-of-function does not alter the overall frequency of tumor-sustaining, cancer stem cells in ERMS, which contrasts with previous studies that defined major roles for NOTCH1, MYF5/MYOD, and WNT signaling in regulating self-renewal and the overall number of tumor sustaining cell types in rhabdomyosarcoma ( Chen et al, 2014 ; Hayes et al, 2018 ; Ignatius et al, 2017 ; Tenente et al, 2017 ).…”
Section: Resultscontrasting
confidence: 99%
“…These, so-called, noncanonical Wnt signalling pathways are highly conserved from Drosophila through to vertebrates and utilise a broad range of cell surface receptors to activate diverse downstream processes [18][19][20] . Wnt-Planar Cell Polarity (Wnt-PCP) signalling represents one of these non-canonical pathways and is required for a number of morphogenic processes in the embryo; 21,22 moreover, Wnt-PCP signalling has been implicated in the pathogenesis of a number of adult diseases and cancers [23][24][25] . Whether Wnt-PCP signalling plays a role in bile duct disease and regeneration has not been determined.…”
mentioning
confidence: 99%
“…From the RNAseq data, we analyzed the expression of the oncogenes that have previously been shown to be upregulated, and characterized as tumorigenic, in RMS. Several such genes were found to be significantly repressed by PROX1 silencing: FGFR4, MYL4 (Khan et al, 2001), IGFBP5, IGF2 (El-Badry et al, 1990; Khan et al, 1999), MYOG (Gryder et al, 2017), MYCN (Williamson et al, 2005), RASSF4 (Crose et al, 2014), VANGL2 (Hayes et al, 2018), Hey1 (Belyea et al, 2011) and NOTCH3 (De Salvo et al, 2014) ( Figure 5A ). Correlation analysis of these genes with PROX1 using RMS tumor RNA expression data in MediSapiens (n = 49 tumors, http://ist.medisapiens.com/) showed significant correlation between PROX1 and six of these genes ( Supplement Figure 3 ), of which one of the strongest correlations was found between PROX1 and FGFR4 ( Figure 5B ).…”
Section: Resultsmentioning
confidence: 95%